Listed

Pfizer Inc: Form 10-K for the period ended Dec 31, 2020

Filed with the SEC on Feb 25, 2021 and accepted by EDGAR at Feb 25, 2021, 13:59 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2020-01-01 to 2020-12-31$41.91bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue12 months2020-01-01 to 2020-12-31$8.69bnus-gaap:CostOfGoodsAndServicesSold
Selling, general and administrative12 months2020-01-01 to 2020-12-31$11.62bnus-gaap:SellingGeneralAndAdministrativeExpense
Interest expense12 months2020-01-01 to 2020-12-31$1.45bnus-gaap:InterestExpense
Income tax12 months2020-01-01 to 2020-12-31$477.0mus-gaap:IncomeTaxExpenseBenefit
Net income12 months2020-01-01 to 2020-12-31$9.62bnus-gaap:NetIncomeLoss
Diluted EPS12 months2020-01-01 to 2020-12-31$1.71us-gaap:EarningsPerShareDiluted
Basic EPS12 months2020-01-01 to 2020-12-31$1.73us-gaap:EarningsPerShareBasic
Diluted shares (weighted)12 months2020-01-01 to 2020-12-315,632,000,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow12 months2020-01-01 to 2020-12-31$14.40bnus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2020-01-01 to 2020-12-31$2.25bnus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Share repurchases12 months2020-01-01 to 2020-12-31$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2020-12-31$1.78bnus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-12-31$35.07bnus-gaap:AssetsCurrent
Total assetsAt period end2020-12-31$154.23bnus-gaap:Assets
Current liabilitiesAt period end2020-12-31$25.92bnus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-12-31$90.76bnus-gaap:Liabilities
Long-term debtAt period end2020-12-31$37.13bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2020-12-31$2.00bnus-gaap:LongTermDebtCurrent
Short-term borrowingsAt period end2020-12-31$556.0mus-gaap:CommercialPaper
Shareholders' equityAt period end2020-12-31$63.24bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000078003-21-000038. Last ingested by Listed: Nov 12, 2026, 18:08 ET. Listed shows no prices and gives no investment advice.